Key Takeaways
- Clinical Bottom Line
- The Legal and Ethical Bedrock of Endoscopy
Clinical Bottom Line
| Procedural Domain | Mandatory Consent Elements | Specifically Quoted Statistics |
|---|---|---|
| Diagnostic Endoscopy | Bleeding, Perforation, Sedation risks. | Perforation risk generally < 1 in 10,000 for standard EGD. |
| Therapeutic Resection (EMR) | Delayed hemorrhage; potential need for urgent surgery. | Delayed bleeding occurs in ~2-5% of large flat polyp resections. |
| ERCP | Post-ERCP Pancreatitis (PEP). | PEP risk is 3-5% broadly, rising drastically in SOD dysfunction. |
The Legal and Ethical Bedrock of Endoscopy
The acquisition of informed consent is far more than a bureaucratic signature; it is a critical communicative process validating patient autonomy. In the high-stakes environment of advanced endoscopy, patients must explicitly comprehend the realistic risks associated with their specific therapeutic intervention, devoid of medical jargon.
Condition-Specific Counseling
Endoscopists must tailor the risk probabilities. For example, quoting a standard 1 in 3,000 perforation risk for a routine screening colonoscopy is appropriate. However, if the patient has a known 4cm laterally spreading tumor (LST) requiring massive mucosal resection, the perforation and bleeding risks escalate exponentially. Furthermore, in procedures like ERCP, the threat of debilitating severe Post-ERCP Pancreatitis must be directly confronted, alongside the mitigating strategies (prophylactic rectal Indomethacin and pancreatic duct stenting) that the team will employ.
Clinical guidelines summarized by the Gastroscholar Research Team. Last updated: 2026. This article is intended for physicians.
